Chemcon Speciality Chemicals Ltd Q2 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/i0aqufpygs0jhwy0v0kjwx3b.pdf

Key Takeaways


Performance & Margin Mechanics

Aggarwal: "If you see the volumes I think this is the first quarter which has resulted into drop in the volumes otherwise the volumes have been consistent. ... one or two quarter can result into drop of the volumes. We do not expect that to run a longer time."

Bromobenzene: The New Growth Pillar


Legacy Portfolio Reset

Aggarwal: "Still if you see there are imports by this companies and we would be hammering them for stopping the imports as far as the total stoppage is concerned. We will be attempting to go ahead with that and hope we are quite confident. We will be successful on that."

New Product Pipeline & Diversification

Aggarwal: "The new products that we are adding we will not be banking purely upon the Pharma but we will be banking upon multiple sector products so that will take care of volatility."

Strategic Investments & Infrastructure

Aggarwal: "I do agree to you that the corporate governance can we consider like that but with the time yes just wait for a quarter you will understand the in principle reason of that."

Guidance & Commitments

CommitmentSpecificsTimeline
Gross profit per kg normalization100% expected to move back to normal levelQ3 FY2023
Volume recovery (HMDS/CMIC)Achieve about 85% to 90% of recovery based on customer discussionsQ4 FY2023
Bromobenzene H2 salesSell ~900 tonnes, value ~₹40 CroresH2 FY2023
Bromobenzene capacity utilizationRamp to 90% capacity utilizationFY2024
Bromobenzene + guanine full utilization2,400 tonnes bromobenzene, 600 tonnes guanine per annumBy 2025
Guanine plant operationalFully operational plant; part sales possible in FY2023FY2024
P10 plant product outPlant completion March 2023, product expectedQ1 FY2024
₹1,000 Crores revenue targetFrom organic growth onlyFive years
4 CBC and 2,5 DHTHope to discontinue these two productsNo date

Key Metrics

MetricQ2 FY23
Revenue₹58 cr, vs ₹61 cr in Q2 FY22
Domestic revenue share29%, international 71%
EBITDA₹9.6 cr, margin 16.6%
Net profit₹7.8 cr
Total production volume1,352 metric tonnes, vs 1,420 metric tonnes in Q2 FY22
HMDS revenue₹29 cr
CMIC revenue₹11 cr
Oilwell completion revenue₹16 cr
H1 FY23 revenue₹147 cr, vs ₹118 cr in H1 FY22
H1 FY23 EBITDA₹43 cr, vs ₹37 cr in H1 FY22
H1 FY23 net profit₹33 cr, vs ₹28 cr in H1 FY22
Net debtNet debt free as of Sep 2022
Bromobenzene H2 FY23 expected sales~900 tonnes, ~₹40 cr
Bromobenzene FY24 expected utilization90%
HMDS current realization~₹650 per kg, 10–12% lower than Q2
CMIC current realization~₹450 per kg, 10–12% lower than Q2
CMIC volume Q2151 metric tonnes (per an analyst's math, unconfirmed by management)